Zelira Therapeutics (AU:ZLD) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Zelira Therapeutics has issued 3.5 million convertible notes valued at $1.4 million to replace a Convertible Loan Agreement. This change reflects a strategic financial move by the company to potentially strengthen its capital structure. Investors may find this development noteworthy as it could impact the company’s financial health and stock performance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.